Drug Interaction Concerns May Negatively Affect HIV Treatment Adherence Among Transgender Women | HIV.gov

Drug Interaction Concerns May Negatively Affect HIV Treatment Adherence Among Transgender Women | HIV.gov

Drug Interaction Concerns May Negatively Affect HIV Treatment Adherence Among Transgender Women

July 24, 2017 - Crossposted from NIAID Newsroom

TOPICS: NIAID, NIH, Research, Transgender, Treatment

Transgender women—people whose birth certificates indicate or once indicated male sex but who identify as women—are at high risk of HIV acquisition, and thus are a key population for HIV prevention and treatment efforts. A new study by researchers supported by the National Institutes of Health and Gilead Sciences reveals that among transgender women in Los Angeles, more than half of those living with HIV were concerned...[READ MORE]